Myelosafe GB Tablet

Overview Myelosafe GB Tablet

Myelosafe GB Tablets, containing lenalidomide, offer therapeutic benefits in managing multiple myeloma, lymphomas, and anemia. Lenalidomide's mechanism involves immunomodulation, stimulating T cell and NK cell counts, suppressing cell growth, exhibiting tumoricidal effects (slowing tumor development), and demonstrating antiangiogenic properties. Dosage should strictly follow physician instructions. This medication is indicated for multiple myeloma, anemia, and mantle cell lymphoma. Store in a cool, dry, and dark location, shielded from sunlight. Always adhere to label instructions, avoid exceeding the prescribed dose, and keep out of children's reach.